Compare Commvault Systems Inc (CVLT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Commvault Systems Inc vs Zimmer Biomet Holdings Inc — how do they compare? Commvault Systems Inc trades at $157.25 (market cap $6.25B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.7× Commvault Systems Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Commvault Systems Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Commvault Systems Inc for 17 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| CVLT | ZBH | |
|---|---|---|
Market Cap | $6.25B | $16.95B |
Volume | 632,727 | 2,505,240 |
Sector | Technology | Health |
52-Week High | $176.52 | $103.98 |
52-Week Low | $75.18 | $79.58 |
Typical Hold Time | 17 Days | 89 Days |
Enterprise Value | $6.24B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVLT trades at $157.25, up 4.64% today, with a bullish technical signal and strong institutional interest. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights include achieving AWS Data Competency and expanding FedRAMP High authorization, reinforcing its cyber resilience leadership.
The outlook is positive, supported by analyst consensus and recent strategic wins, though high valuation multiples and a projected decline in net profit margin for 2026 present risks. Upside potential exists if earnings momentum continues, but investors should weigh premium valuations against growth sustainability.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Commvault Systems Inc
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
